
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
Collene Jeter, Bigang Liu, Yue Lu, et al.
Cell Discovery (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 54
Collene Jeter, Bigang Liu, Yue Lu, et al.
Cell Discovery (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Loss and revival of androgen receptor signaling in advanced prostate cancer
Nicolò Formaggio, Mark A. Rubin, Jean‐Philippe Theurillat
Oncogene (2021) Vol. 40, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 104
Nicolò Formaggio, Mark A. Rubin, Jean‐Philippe Theurillat
Oncogene (2021) Vol. 40, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 104
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 50
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 50
Coding, or non-coding, that is the question
Laura Poliseno, Martina Lanza, Pier Paolo Pandolfi
Cell Research (2024) Vol. 34, Iss. 9, pp. 609-629
Open Access | Times Cited: 20
Laura Poliseno, Martina Lanza, Pier Paolo Pandolfi
Cell Research (2024) Vol. 34, Iss. 9, pp. 609-629
Open Access | Times Cited: 20
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Qiuhui Li, Qu Deng, Hsueh‐Ping Chao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 124
Qiuhui Li, Qu Deng, Hsueh‐Ping Chao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 124
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Dingxiao Zhang, Dean G. Tang, Kiera Rycaj
Seminars in Cancer Biology (2018) Vol. 52, pp. 94-106
Open Access | Times Cited: 121
Dingxiao Zhang, Dean G. Tang, Kiera Rycaj
Seminars in Cancer Biology (2018) Vol. 52, pp. 94-106
Open Access | Times Cited: 121
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 116
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 116
Overview of Cancer Stem Cells and Stemness for Community Oncologists
Justin D. Lathia, Huiping Liu
Targeted Oncology (2017) Vol. 12, Iss. 4, pp. 387-399
Open Access | Times Cited: 113
Justin D. Lathia, Huiping Liu
Targeted Oncology (2017) Vol. 12, Iss. 4, pp. 387-399
Open Access | Times Cited: 113
Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Sukanya Basu, Dong Yang, Rahul Kumar, et al.
Seminars in Cancer Biology (2021) Vol. 78, pp. 90-103
Open Access | Times Cited: 87
Sukanya Basu, Dong Yang, Rahul Kumar, et al.
Seminars in Cancer Biology (2021) Vol. 78, pp. 90-103
Open Access | Times Cited: 87
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
Alastair Davies, Amina Zoubeidi, Luke A. Selth
Endocrine Related Cancer (2019) Vol. 27, Iss. 2, pp. R35-R50
Open Access | Times Cited: 76
Alastair Davies, Amina Zoubeidi, Luke A. Selth
Endocrine Related Cancer (2019) Vol. 27, Iss. 2, pp. R35-R50
Open Access | Times Cited: 76
Nanog, as a key cancer stem cell marker in tumor progression
Parisa Vasefifar, Rouhollah Motafakkerazad, Leili Aghebati‐Maleki, et al.
Gene (2022) Vol. 827, pp. 146448-146448
Closed Access | Times Cited: 69
Parisa Vasefifar, Rouhollah Motafakkerazad, Leili Aghebati‐Maleki, et al.
Gene (2022) Vol. 827, pp. 146448-146448
Closed Access | Times Cited: 69
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
Anastasia C. Hepburn, Rebecca E. Steele, Rajan Veeratterapillay, et al.
Oncogene (2019) Vol. 38, Iss. 22, pp. 4412-4424
Open Access | Times Cited: 74
Anastasia C. Hepburn, Rebecca E. Steele, Rajan Veeratterapillay, et al.
Oncogene (2019) Vol. 38, Iss. 22, pp. 4412-4424
Open Access | Times Cited: 74
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
Song Liu, Sangeeta Kumari, Qiang Hu, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 68
Song Liu, Sangeeta Kumari, Qiang Hu, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 68
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer
Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels, et al.
Cell Reports (2019) Vol. 29, Iss. 4, pp. 889-903.e10
Open Access | Times Cited: 58
Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels, et al.
Cell Reports (2019) Vol. 29, Iss. 4, pp. 889-903.e10
Open Access | Times Cited: 58
Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression
Haoran Chen, Su-Ping Fang, Xudong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Haoran Chen, Su-Ping Fang, Xudong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Shuo Zhang, Rui Yang, Yujie Ouyang, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 985-1020
Open Access | Times Cited: 6
Shuo Zhang, Rui Yang, Yujie Ouyang, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 985-1020
Open Access | Times Cited: 6
Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis
Zeyaul Islam, Ameena M. Ali, Adviti Naik, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 36
Zeyaul Islam, Ameena M. Ali, Adviti Naik, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 36
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
Kentaro Inamura
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14723-14737
Open Access | Times Cited: 45
Kentaro Inamura
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14723-14737
Open Access | Times Cited: 45
Androgen receptor co-regulation in prostate cancer
Dhirodatta Senapati, Sangeeta Kumari, Hannelore V. Heemers
Asian journal of urology (2019) Vol. 7, Iss. 3, pp. 219-232
Open Access | Times Cited: 36
Dhirodatta Senapati, Sangeeta Kumari, Hannelore V. Heemers
Asian journal of urology (2019) Vol. 7, Iss. 3, pp. 219-232
Open Access | Times Cited: 36
The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future
Yong Zhou, Tian Li, Man Jia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7482-7482
Open Access | Times Cited: 12
Yong Zhou, Tian Li, Man Jia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7482-7482
Open Access | Times Cited: 12
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer
Samuel P. Pitzen, Amber N. Rudenick, Yinjie Qiu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Samuel P. Pitzen, Amber N. Rudenick, Yinjie Qiu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
Daisuke Obinata, Ken‐ichi Takayama, Satoru Takahashi, et al.
Cancers (2017) Vol. 9, Iss. 3, pp. 22-22
Open Access | Times Cited: 38
Daisuke Obinata, Ken‐ichi Takayama, Satoru Takahashi, et al.
Cancers (2017) Vol. 9, Iss. 3, pp. 22-22
Open Access | Times Cited: 38
The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells
Jakob Püschel, Anna Dubrovska, Ielizaveta Gorodetska
Cancers (2021) Vol. 13, Iss. 18, pp. 4703-4703
Open Access | Times Cited: 24
Jakob Püschel, Anna Dubrovska, Ielizaveta Gorodetska
Cancers (2021) Vol. 13, Iss. 18, pp. 4703-4703
Open Access | Times Cited: 24
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
Qinju He, Yuanzhen Zhang, Wenchao Li, et al.
Cancer Letters (2024) Vol. 602, pp. 217214-217214
Closed Access | Times Cited: 3
Qinju He, Yuanzhen Zhang, Wenchao Li, et al.
Cancer Letters (2024) Vol. 602, pp. 217214-217214
Closed Access | Times Cited: 3
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
Qiuhui Li, Bigang Liu, Hsueh‐Ping Chao, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Qiuhui Li, Bigang Liu, Hsueh‐Ping Chao, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 26